Approval · Notice of Compliance 4124 · 1997
TAMONE: Notice of Compliance 4124
Issued October 10, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4124
- Date
- October 10, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Provides for revisions to the product monograph
- Therapeutic class
- Antineoplastic (non-steroidal antiestrogen) agent
- Canadian reference product
- NOLVADEX (Zeneca Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TAMONE | Not yet assigned | — |
Medicinal ingredients
- TAMOXIFEN CITRATE 10 MG per TAB
- TAMOXIFEN CITRATE 20 MG per TAB